JP Morgan Chase’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

JP Morgan Chase’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2	Closed	-$12	–	8041
2023 Q3	$12	Sell	2 -15	-88%	-$167	﹤0.01%	7274
2023 Q2	$242	Buy	+17	New	+$289	﹤0.01%	6618

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

JP Morgan Chase's ZIVO Position: Q4 2023 in Review

JP Morgan Chase sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 2 shares — an estimated $12 sold.

JP Morgan Chase first reported a position in ZIVO in Q2 2023 and held it in 2 quarters. The position peaked at $242 in Q2 2023. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

JP Morgan Chase reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
JP Morgan Chase sold 2 Zivo Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $12.
JP Morgan Chase first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
JP Morgan Chase's Zivo Bioscience, Inc. Common Stock position peaked at $242 in Q2 2023.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.